GLP1R and diabetes mellitus: On the other hand, GLP-1 RA showed similar cardiovascular outcomes, in particular in patients affected by diabetes and CAD, acting on lipid profile, endothelial cell function, ischemia-reperfusion processes, and inflammation pathways, such as the downregulation of multiples cytokines and the restraint on local intestinal inflammation.